ArticleGene therapy2009

Ad5/3-9HIF-Delta24-VEGFR-1-Ig, an infectivity enhanced, dual-targeted and antiangiogenic oncolytic adenovirus for kidney cancer treatment.

K Guse et al.PubMed ↗Publisher ↗

No numbers read from the abstract.